LRMRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Larimar Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$2.12+0.14 (+6.80%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Larimar Therapeutics has not reported a dividend
No dividend per share appears in Larimar Therapeutics's annual filings since fiscal 2011.